The phrase "a significant decrease in blood glucose" is correct and usable in written English.
It can be used in medical or scientific contexts when discussing changes in blood glucose levels, particularly in relation to health, diet, or diabetes management.
Example: "After implementing the new diet plan, the patient experienced a significant decrease in blood glucose, which was a positive outcome."
Alternatives: "a notable reduction in blood glucose" or "a marked decline in blood glucose".
daily for 28 days in STZ induced diabetic rats, resulted in a significant decrease in blood glucose, glycosylated hemoglobin, SGOT, SGPT, ALP serum urea and creatinine with significant rise in plasma insulin level.
The obtained results revealed that S. alexandrina contains scopoletin, xanthotoxin, apigenin, luteolin, quercetin-7-O-rhaminoside and luteolin-7-O-glucoside, also it showed a significant decrease in blood glucose level, liver functions (ALT, AST, TP), also a significant anti-ulcer effect.
Surprisingly, a significant decrease in blood glucose appeared.
Within the first 3 months of ARB therapy, a significant decrease in blood glucose level was noted.
Interestingly, supplementation of TPEE or orlistat to obese rats elicited a significant decrease in blood glucose level at 60 min and beyond when compared with HFD control rats.
At 120 min after injection, ViL and ViLVaL treatment groups displayed a significant decrease in blood glucose levels compared with the VaL group.
Significant decrease in blood glucose level together with significant increase in serum insulin level were observed after treatment with N. sativa oil for 4 weeks.
Glibenclamide and HIE Groupp 3 and 4) produced significant decrease in blood glucose level when compared to the diabetic control (Group 2) after 6 days of treatment.
Ft at all doses (0.4, 0.8 and 1.6 mg/kg) showed significant decrease in blood glucose level after 6 h dropping by 36.1, 34.1 and 51.2 %, respectively.
Elder extract showed significant decrease in blood glucose level after 6 h at all doses (50, 100 and 200 mg/kg) with the glucose level dropping by 41.1, 43.8 and 46.1 %, respectively.
Our study may enable us to reanalyze our previous published trial on tight blood glucose control, which was characterized by a significant decrease in mean blood glucose with a significant increase in hypoglycemia rate without any impact on mortality [ 7].
